Intervention Guidelines for Neonatal Hyperbilirubinemia: An Evidence Based Quagmire

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|25|2939-2945

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.25, 2009-09, pp. : 2939-2945

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bilirubin and the Genome: The Hereditary Basis of Unconjugated Neonatal Hyperbilirubinemia

By  

Current Pharmacogenomics, Vol. 3, Iss. 1, 2005-03 ,pp. : 21-42

Bentham Science Publishers

Access to resources Recommend Favorite

Advance care planning: concise evidence-based guidelines

By Conroy Simon   Fade Premila   Fraser Aileen   Schiff Rebekah  

Clinical Medicine, Vol. 9, Iss. 1, 2009-02 ,pp. : 76-79

Royal College Of Physicians

Access to resources Recommend Favorite

Physicians prefer clinical guidelines based on evidence

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 405, 2003-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Pharmacological Therapies for Pediatric and Neonatal ALI/ARDS: An Evidence-Based Review

By  

Current Drug Targets, Vol. 13, Iss. 7, 2012-06 ,pp. : 906-916

Bentham Science Publishers

Access to resources Recommend Favorite

Evidence-based guidelines for the pharmacological management of acute migraine attacks

By  

Inpharma, Vol. 1, Iss. 1369, 2003-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite